JP Patent

JP5552700B2 — 血管腫の治療用の薬剤を製造するためのβ遮断薬の使用

Assigned to Centre Hospitalier Universitaire de Bordeaux · Expires 2014-07-16 · 12y expired

What this patent protects

Patent listed against propranolol-hydrochloride.

Drugs covered by this patent

propranolol-hydrochloride (PROPRANOLOL HYDROCHLORIDE)

Patent Metadata

Patent number: JP5552700B2
Jurisdiction: JP
Classification: —
Expires: 2014-07-16
Drug substance claim: No
Drug product claim: No
Assignee: Centre Hospitalier Universitaire de Bordeaux
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.